These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Lack of sequence variations in THAP1 gene and THAP1-binding sites in TOR1A promoter of DYT1 patients. Palada V; Stiern S; Glöckle N; Gómez-Garre P; Carrillo F; Mir P; Szczaluba K; Tinazzi M; Ajena D; Romani M; Valente EM; Müller U; Bauer P; Riess O; Ott T; Grundmann K Mov Disord; 2012 Jun; 27(7):917. PubMed ID: 22508326 [No Abstract] [Full Text] [Related]
8. Dystonia-Causing Mutations as a Contribution to the Etiology of Spasmodic Dysphonia. de Gusmão CM; Fuchs T; Moses A; Multhaupt-Buell T; Song PC; Ozelius LJ; Franco RA; Sharma N Otolaryngol Head Neck Surg; 2016 Oct; 155(4):624-8. PubMed ID: 27188707 [TBL] [Abstract][Full Text] [Related]
9. Mutation screening of the DYT6/THAP1 gene in Italy. Bonetti M; Barzaghi C; Brancati F; Ferraris A; Bellacchio E; Giovanetti A; Ialongo T; Zorzi G; Piano C; Petracca M; Albanese A; Nardocci N; Dallapiccola B; Bentivoglio AR; Garavaglia B; Valente EM Mov Disord; 2009 Dec; 24(16):2424-7. PubMed ID: 19908325 [TBL] [Abstract][Full Text] [Related]
10. DYT 6--a novel THAP1 mutation with excellent effect on pallidal DBS. Jech R; Bareš M; Křepelová A; Urgošík D; Havránková P; Růžička E Mov Disord; 2011 Apr; 26(5):924-5. PubMed ID: 21425341 [No Abstract] [Full Text] [Related]
11. Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin. Brin MF; Blitzer A; Stewart C Adv Neurol; 1998; 78():237-52. PubMed ID: 9750921 [No Abstract] [Full Text] [Related]
12. [Treatment of spasmodic dysphonia with botulinum toxin]. Klap P; Marion MH; Perrin A; Fresnel-Elbaz E Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624 [TBL] [Abstract][Full Text] [Related]
13. Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series. Blitzer A Eur J Neurol; 2010 Jul; 17 Suppl 1():28-30. PubMed ID: 20590805 [TBL] [Abstract][Full Text] [Related]
14. [Patterns of spasmodic dysphonia and botulinum toxin injections]. Xu W; Han DM; Hou LZ; Zhang L; Gao YH; Ye JY; Wang J Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Apr; 40(4):253-7. PubMed ID: 16008256 [TBL] [Abstract][Full Text] [Related]
15. DYT6 dystonia: mutation screening, phenotype, and response to deep brain stimulation. Groen JL; Ritz K; Contarino MF; van de Warrenburg BP; Aramideh M; Foncke EM; van Hilten JJ; Schuurman PR; Speelman JD; Koelman JH; de Bie RM; Baas F; Tijssen MA Mov Disord; 2010 Oct; 25(14):2420-7. PubMed ID: 20687191 [TBL] [Abstract][Full Text] [Related]
16. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia. Stong BC; DelGaudio JM; Hapner ER; Johns MM Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357 [TBL] [Abstract][Full Text] [Related]
17. Screening of Brazilian families with primary dystonia reveals a novel THAP1 mutation and a de novo TOR1A GAG deletion. De Carvalho Aguiar P; Fuchs T; Borges V; Lamar KM; Silva SM; Ferraz HB; Ozelius L Mov Disord; 2010 Dec; 25(16):2854-7. PubMed ID: 20925076 [TBL] [Abstract][Full Text] [Related]
18. Singular DYT6 phenotypes in association with new THAP1 frameshift mutations. Blanchard A; Roubertie A; Simonetta-Moreau M; Ea V; Coquart C; Frederic MY; Gallouedec G; Adenis JP; Benatru I; Borg M; Burbaud P; Calvas P; Cif L; Damier P; Destee A; Faivre L; Guyant-Marechal L; Janik P; Janoura S; Kreisler A; Lusakowska A; Odent S; Potulska-Chromik A; Rudzińska M; Thobois S; Vuillaume I; Tranchant C; Tuffery-Giraud S; Coubes P; Sablonnière B; Claustres M; Collod-Béroud G Mov Disord; 2011 Aug; 26(9):1775-7. PubMed ID: 21520283 [No Abstract] [Full Text] [Related]
19. Novel THAP1 variants in Brazilian patients with idiopathic isolated dystonia. da Silva-Junior FP; dos Santos CO; Silva SM; Barbosa ER; Borges V; Ferraz HB; Limongi JC; Rocha MS; de Carvalho Aguiar P J Neurol Sci; 2014 Sep; 344(1-2):190-2. PubMed ID: 24976531 [TBL] [Abstract][Full Text] [Related]
20. Truncating mutations in THAP1 define the nuclear localization signal. Osmanovic A; Dendorfer A; Erogullari A; Uflacker N; Braunholz D; Rakovic A; Vierke G; Gil-Rodríguez C; Münchau A; Albrecht M; Brüggemann N; Gillessen-Kaesbach G; Klein C; Lohmann K; Kaiser FJ Mov Disord; 2011 Jul; 26(8):1565-7. PubMed ID: 21495072 [No Abstract] [Full Text] [Related] [Next] [New Search]